Skip to main content
. 2016 Sep 9;6(3):382–395. doi: 10.1159/000448214

Table 1.

TEAEs in study 326 and in the Asian subanalysis [10,23]

Parameter Study 326 [10]
Asian subanalysis [23]
Donepezil 23 mg/day (n = 963) Donepezil 10 mg/day (n = 471) Donepezil 23 mg/day (n = 145) Donepezil 10 mg/day (n = 78)
Patients with at least 1 TEAE 73.7 63.7 82.1 71.8
TEAEs
 Nausea 11.8 3.4 15.9 6.4
 Vomiting 9.2 2.5 15.2 3.8
 Diarrhea 8.3 5.3 6.9 3.8
 Anorexia 5.3 1.7 10.3 2.6
 Dizziness 4.9 3.4 8.3 6.4
 Weight decrease 4.7 2.5 5.5 3.8
 Headache 4.3 3.2 6.9 3.8
Patients who discontinued due to TEAEs 18.6 7.9 21.4 10.3
Most common TEAEs leading to discontinuation
 Vomiting 2.9 0.4 4.1 1.3
 Nausea 1.9 0.4 2.1 0

Values are percentages.